Medications

FDA approves biosimilar ogivri for breast, stomach cancers

(HealthDay)—Ogivri (trastuzumab-dkst) has been approved by the U.S. Food and Drug Administration as the nation's first biosimilar drug to treat certain breast and stomach cancers, the agency said Friday in a news release.

Surgery

The future of sutures and staples: A sealant inspired by slugs

Although sutures and staples have been used for decades to close wounds or surgical incisions, both have their drawbacks: suturing can be time-consuming and can lead to extended and costly procedures, while staples are limited ...

Cardiology

Blood cancer gene could be key to preventing heart failure

A new study, published today in Circulation, shows that the gene Runx1 increases in damaged heart muscle after a heart attack. An international collaboration led by researchers from the University of Glasgow, found that mice ...

Cardiology

New way to detect heart damage caused by chemotherapy

The high-tech scanning techniques were enabled by funding from the British Heart Foundation (BHF), and could reveal whether chemotherapy is damaging a person's heart before any symptoms appear.

Cardiology

Teens also at risk for organ damage from high blood pressure

Organ damage from high blood pressure doesn't only occur in adults; it can also happen in teenagers, according to research presented today at the American Heart Association (AHA) Council on Hypertension, AHA Council on Kidney ...

Cardiology

Physical activity may ward off heart damage

Physical activity can lower the risk of heart damage in middle-aged and older adults and reduce the levels of heart damage in people who are obese, according to research published today in JACC: Heart Failure.

page 14 from 32